Charles F Louis

Title: The Innovations of Charles F Louis

Introduction

Charles F Louis is a notable inventor based in Saint Paul, MN (US). He has made significant contributions to the field of medical diagnostics, particularly in relation to malignant hyperthermia susceptibility. With a total of 2 patents, his work has the potential to impact patient care and treatment options.

Latest Patents

Louis's latest patents focus on diagnosing malignant hyperthermia susceptibility. The first patent describes a method for diagnosing this condition by detecting abnormal ryanodine receptor fragments. These fragments are identified following proteolytic enzyme digestion of ryanodine receptors isolated from the sarcoplasmic reticulum of mammalian skeletal muscle. The detection of these abnormal fragments serves as an indicator of malignant hyperthermia susceptibility. This innovative approach could lead to more accurate diagnoses and better management of the condition.

Career Highlights

Throughout his career, Charles F Louis has worked with esteemed institutions such as the University of Iowa Research Foundation and the University of Minnesota. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Kevin P Campbell and C Michael Knudson. Their collaborative efforts have further advanced the understanding and diagnosis of malignant hyperthermia susceptibility.

Conclusion

Charles F Louis's contributions to medical diagnostics through his patents and collaborations highlight his dedication to improving patient outcomes. His innovative methods for diagnosing malignant hyperthermia susceptibility represent a significant advancement in the field.